Package Leaflet: Information for the User
Hydrocortisone Normon 100 mg Powder and Solvent for Solution for Injection and Infusion EFG
Hydrocortisone (as sodium succinate)
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Contents of the pack
Hydrocortisone Normon contains hydrocortisone as sodium succinate. Hydrocortisone belongs to a group of medicines called corticosteroids or steroids. Corticosteroids are produced naturally in our body and are important for many functions of our body.
The use of extra corticosteroids, such as hydrocortisone, is an effective way to treat various diseases that involve inflammatory processes of the body. Hydrocortisone reduces this inflammation, which could otherwise worsen. You should take this medicine regularly to get the most benefit.
Corticosteroids can also help treat shocksafter surgeries or injuries, hypersensitivity reactions (anaphylactic) or other stressful conditions. These include inflammatory or allergic conditions that affect:
This medicine may be prescribed to treat conditions other than those listed above, such as adrenal insufficiency and other medical emergencies such as shock treatment associated with this. Treatment of organ transplant rejection or other medical conditions such as myxedema coma, necrotizing vasculitis, and rheumatoid arthritis.
You should consult a doctor if you do not feel better or if you feel worse or if you are not sure why you have been given this medicine.
Do not use Hydrocortisone Normon
This medicine should not be injected:
Children and adolescents
This medicine should be administered with caution in children as prolonged use interferes with the child's growth and development and may cause them cataracts.
If hydrocortisone is administered to premature newborns, monitoring of heart function and structure may be necessary.
Consult your doctor immediately in any of the above cases.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Hydrocortisone Normon
Tell your doctor before taking this medicine if you are in any of the following situations. Your doctor may need to monitor your treatment more closely, modify your dose, or give you another medicine.
Corticosteroids should be used with caution, as they can cause an eye condition (central serous chorioretinopathy), in which a buildup of fluid forms under the layer of light-sensitive tissue in the back of the inner eye (retina), causing visual impairment and potentially leading to retinal detachment.
Long-term corticosteroid therapy at high doses may cause an abnormal amount of fat deposit in or outside the lining of the spinal column (epidural lipomatosis).
Use in athletes:
Athletes are warned that this medicine contains a component that may result in a positive doping control test.
Other medicines and Hydrocortisone Normon
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines.
You must tell your doctor if you are using any of the following medicines, which may affect how Hydrocortisone works or any other medicine:
If you are taking medication continuously.
If you are being treated for diabetes, high blood pressure, or fluid retention (edema), tell your doctor, as you may need to adjust the dose of the medicines used to treat these conditions.
Before undergoing surgery,inform your doctor, dentist, or anesthetist to indicate that you are taking this medicine.
If you need your doctor to perform a test or in the hospital, it is essential that you inform your doctor or nurse that you are taking this medicine. This medicine may affect the results of some tests.
Pregnancy and breastfeeding
Pregnancy
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine, as it may delay the growth of the baby. Corticosteroids can cross the placenta, which is a risk associated with low birth weight.
Cataracts have been observed in babies born to mothers treated with corticosteroids for a long time during pregnancy.
Breastfeeding
Tell your doctor if you are breastfeeding, as small amounts of corticosteroids may be found in breast milk. If you continue breastfeeding while being treated, your baby will need to undergo extra tests to ensure that they are not being affected by this medicine.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
The effect of this class of medicines on the ability to drive or use machines has not been studied. Given that side effects such as seizures can occur with the use of corticosteroids, you should not drive or use machines if you have these symptoms.
Hydrocortisone Normon contains sodium.
This medicine contains less than 1mmol of sodium (23mg) per vial; this is, essentially “sodium-free”
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Dosing information
Your doctor will decide the injection site, the amount of medicine, and how many injections you will receive, depending on the condition being treated and its severity. Your doctor will inject the lowest dose for the shortest time possible to achieve effective relief of your symptoms. Your doctor may also want you to take a second type of steroid or a salt supplement to help you balance the salt.
Adults
Your doctor or nurse will administer this medicine to you as an injection, either into a vein (intravenously) or into a muscle (intramuscularly). The first dose is usually given into a vein, especially in emergency situations.
It will be administered slowly over a period of 1 - 10 minutes. Depending on your situation, a repeated dose may be injected at intervals of 2 to 6 hours. Normally, high doses can only be used for two or three days.
This medicine is first dissolved in sterile water for injectable preparations. If the medicine is to be administered by infusion (via pump or drip), it is also mixed with another suitable liquid. No other medicines should be mixed.
Elderly patients
Treatment will normally be the same as for younger adults. However, your doctor may want to see you more regularly to check how you are getting on with this medicine.
Use in children and adolescents
Corticosteroids can affect the growth of children, so your doctor will prescribe the effective lowest dose (not less than 25 mg per day).
If you use more Hydrocortisone Normon than you should
If you think you have had more injections of this medicine than you should, talk to your doctor immediately.
If you miss a dose of Hydrocortisone Normon
Since this medicine will be administered under close medical supervision, it is unlikely that you will not be given a dose. However, you should inform your doctor if you think you have missed a dose.
If you stop treatment with Hydrocortisone Normon
Your doctor will decide when it is time to stop your treatment. You will need to stop this treatment slowly if:
You should stop this medicine slowly to avoid withdrawal symptoms. These symptoms can include skin itching, fever, muscle and joint pain, runny nose, sticky eyes, sweating, and weight loss.
If your symptoms seem to return or worsen as the dose of this medicine is reduced, inform your doctor immediately.
Mental health problems while taking this medicine
Mental health problems can occur while taking steroids like this medicine (see also section 4, Possible side effects).
Talk to a doctor if you (or someone taking this medicine) show signs of mental problems. This is particularly important if you are depressed or could be thinkingabout suicide. In some cases, mental problems have occurred when doses were reduced or stopped.
If you have any other questions about the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Your doctor may have prescribed this medicine because your illness is not being treated properly and could worsen.
In certain medical conditions, medications like Hydrocortisone (steroids) should not be stopped abruptly. If you experience any of the following symptoms, seek immediate attention.
Your doctor will then decide if you should continue taking your medication.
If you experience any of the following adverse effects, or if you notice any other unusual effect not mentioned in this prospectus, inform your doctor immediately.
The frequency of side effects is unknown. The frequency cannot be estimated from the available data.
Blood, heart, and circulation
Body water and salts
Digestive system
Ears
Eyes
General disorders
Hormones and metabolic system
Muscles and bones
Nerves and mood problems
Steroids, including this medication, can cause serious mental health problems.
These are common in both adults and children. They can affect approximately 5 out of 100 people taking medications like this.
Other nervous system side effects may include:
Skin
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the label and box after "CAD". The expiration date is the last day of the month indicated.
Store below 30°C.
Keep in the original packaging to protect it from light.
Solution after reconstitution and dilution:
The chemical and physical stability of the solution has been demonstrated for 4 hours if stored at 25°C.
From a microbiological point of view, unless the reconstitution method excludes the risk of microbial contamination, the product must be used immediately.
If not used immediately, the in-use storage times and conditions are the responsibility of the user.
Medicines should not be thrown down the drain or into the trash. Ask your pharmacist how to dispose of the packaging and medications you no longer need. These measures will help protect the environment.
Composition of Hydrocortisone Normon
Each ampoule of solvent contains 2 ml of water for injectable preparations.
The solvent does not contain excipients.
Appearance of the product and package contents
This medication is presented in vials containing a sterile white or almost white lyophilized powder and ampoules with 2 ml of water for injectable preparations.
The lyophilized powder is presented in 2 ml type I colorless glass vials, and the solvent in 2 ml type I colorless glass ampoules.
This medication is available in clinical packages containing 50 vials and 50 solvent ampoules or packages containing 1 vial and 1 solvent ampoule.
Marketing authorization holder and manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6
28760 Tres Cantos
Madrid (SPAIN)
Date of the last revision of this prospectus:
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
-------------------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
For more information, consult the Product Technical Sheet.
Posology and method of administration.
This medication can be administered by intravenous injection, intravenous infusion, or intramuscular injection. The preferred method for initial emergency use is intravenous injection. After the initial emergency period, the use of a long-acting injectable preparation or an oral preparation should be considered.
The dose generally ranges from 100 mg to 500 mg, depending on the severity of the condition, administered by intravenous injection over a period of 1 to 10 minutes. The dose may be repeated at intervals of 2, 4, or 6 hours as indicated by the response and the patient's clinical condition.
Dose requirements are variable and must be individualized based on the disease being treated, its severity, and the patient's response throughout the duration of treatment. A risk/benefit decision must be made in each individual case on an ongoing basis.
The appropriate maintenance dose should be determined by decreasing the initial dose of the medication in small decrements at appropriate time intervals until the lowest dose is reached, which will maintain an adequate clinical response.
In general, treatment with high doses of corticosteroids should only be continued until the patient's condition has stabilized, which is usually no more than 48 to 72 hours. When treatment with high doses of hydrocortisone needs to be continued beyond 72 hours, hypernatremia may occur. In such circumstances, it may be necessary to replace this medication with another corticosteroid, such as sodium metylprednisolone succinate, as it causes little or no sodium retention.
If the medication needs to be discontinued after long-term treatment, it should be withdrawn gradually rather than abruptly (see section 4.4 of the technical sheet).
Adverse effects can be minimized by using the effective lowest dose for the minimum period (see section 4.4 of the technical sheet).
Treatment with corticosteroids is a complement and not a replacement for conventional treatment.
In patients with liver disease, there may be an increased effect (see section 4.4 of the technical sheet), so a dose reduction should be considered.
Elderly population: Hydrocortisone is mainly used in acute short-term conditions. When used according to the instructions, there is no information that justifies a change in the dose in these people. However, treatment of elderly patients should be planned taking into account the more serious consequences of common corticosteroid side effects in this age group, and closer clinical monitoring is required (see section 4.4 of the technical sheet).
Pediatric population:While the dose may be reduced for babies and children, it is more governed by the severity of the condition and the patient's response than by age or body weight, but it should not be less than 25 mg per day (see Section 4.4 of the technical sheet).
This medication is not recommended for intrathecal use.
Method of administration
Preparation of solutions:
For intravenous or intramuscular administration, prepare the solution aseptically by adding up to 2 ml of sterile water for injectable preparations to the vial containing the lyophilized powder, shaking, and withdrawing the amount to be used.
The reconstituted solution is isotonic or almost isotonic.
For intravenous infusion, first prepare the solution by adding up to 2 ml of sterile water for injectable preparations to the vial. This solution can be added to 100 ml - 1000 ml (but not less than 100 ml) of 5% dextrose in water (or isotonic saline solution if the patient has no sodium restriction).
This medication should not be mixed with other medications, except those mentioned in section 6.6 of the Technical Sheet.
When reconstituted, the pH of the solution will vary from 7.0 to 8.0.
Parenteral pharmaceutical products should be visually inspected for particles and discoloration before administration. The reconstituted solution should be clear without visible particles.
Elimination:
Any unused medication or waste material must be disposed of in accordance with local requirements.